A director at Veeva Systems Inc sold 3,882 shares at 216.830USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
The independent financial analyst theScreener just awarded an improved star rating to VEEVA SYSTEMS INC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date February...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Jones Lang LaSalle (JLL) is one of the most important platforms for helping commercial real estate (CRE) firms adapt to the new post-pandemic normal they're going to have to change for, in terms of both demand and type of office usage after the At-Home Revolution. It is one of the two largest players in helping CRE firms in terms of financing, buying and selling properties, managing properties, project development and strategy consulting, basically everything end-to-end they need to do. Being p...
Veeva Systems Inc. (VEEV:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings with a 108.4x Uniform P/E, implying bullish expectations for the firm. However, management appears concerned about pharmaceutical sales force reductions, Data Cloud's potential, and Vault platform competition. Specifically, management may lack confidence in their ability to maintain travel and operating cost savings post-COVID and continue commercializing their patient data product. I...
Current market expectations for II-VI Incorporated (IIVI) don't comprehend the company's macro tailwinds. The company supplies the technology that allows big macro trends around 5G, the Internet of Things, and autonomous vehicles to bloom. Its tailwinds from these markets continue to take off, and in the case of autonomous vehicles, it is essential to any success at all. As booming demand accelerates in these end markets, the company's likely to see strong fundamental momentum the market i...
Veeva Systems Inc. (VEEV:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings with a 91.6x Uniform P/E, implying bullish expectations for the firm. However, management appears concerned about billings growth, contract research organization (CRO) partnerships, and the Vault platform Specifically, management may lack confidence in their ability to sustain record wins for Quality and Regulatory, maintain strong total billings improvements, and cultivate further Co...
BARCELONE, Espagne--(BUSINESS WIRE)-- (NYSE : VEEV) a annoncé aujourd'hui que TFS HealthScience avait choisi pour la gestion d’études de bout en bout sur une plateforme cloud unique. L’ORC mondiale prend des mesures pour moderniser davantage ses opérations d’étude, en adoptant l’intégralité de la suite logicielle pour améliorer l'efficacité et la rapidité des essais. TFS HealthScience proposera désormais à ses clients biopharmaceutiques des technologies et des services leaders du secteur afin de réaliser des études plus économiques et plus conformes. « La Veeva Vault Clinical Operations Sui...
PLEASANTON, Calif.--(BUSINESS WIRE)-- (NYSE: VEEV) today announced that TFS HealthScience selected for end-to-end study management on a single cloud platform. The global CRO is taking action to further modernize study operations, adopting the entire suite for greater efficiency and speed in trials. Now TFS HealthScience will offer its biopharma customers industry-leading technologies and services to run more cost-efficient and compliant studies. "Veeva Vault Clinical Operations Suite gives us a foundation for further growth as we expand our service offerings globally," said Dr. Bassem Saleh...
BARCELONA, Spain--(BUSINESS WIRE)-- (NYSE: VEEV) today announced that TFS HealthScience selected for end-to-end study management on a single cloud platform. The global CRO is taking action to further modernize study operations, adopting the entire suite for greater efficiency and speed in trials. Now TFS HealthScience will offer its biopharma customers industry-leading technologies and services to run more cost-efficient and compliant studies. "Veeva Vault Clinical Operations Suite gives us a foundation for further growth as we expand our service offerings globally," said Dr. Bassem Saleh, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.